在炎症性肠病的早期阶段,近期的进展和潜在的多组体方法
Iago Rodríguez-Lago1,2,3, Jonathan Blackwell4, Beatriz Mateos5
1Gastroenterology Department, Hospital Universitario de Galdakao, 48960 Galdakao, Spain.
Journal of clinical medicine
|May 27, 2023
概括
临床前炎症性肠病 (IBD) 的早期检测至关重要. 新的奥米克技术可能有助于在诊断前几年识别免疫变化和病变,改善患者的治疗结果并降低医疗保健成本.
科学领域:
- 胃肠道学和免疫学
- 生物标志物发现发现
背景情况:
- 炎症性肠病 (IBD) 导致严重的胃肠道症状并影响生活质量.
- 迟迟诊断IBD有助于疾病的进展和增加医疗负担.
- 有证据表明IBD存在临床前阶段,类似于其他免疫介导疾病.
研究的目的:
- 审查目前关于临床前炎症性肠病 (IBD) 的研究结果.
- 探索omics技术在识别IBD早期阶段的潜力.
- 强调早期干预在IBD管理中的重要性.
主要方法:
- 关于临床前IBD的最新研究的文献综述.
- 对早期免疫反应变化和内镜病变的证据分析.
- 讨论用于早期检测的omics技术 (基因组学,蛋白质组学,代谢组学).
主要成果:
- 免疫反应和内镜检查结果的临床前变化可以在IBD诊断之前几年.
- 奥米克斯技术为确定临床前IBD生物标志物提供了有前途的途径.
- 早期检测可以实现及时干预,可能改变疾病的进程.
结论:
- 人们越来越认识到IBD的临床前阶段.
- 欧米克技术即将彻底改变早期IBD检测和诊断.
- 专注于临床前阶段对于改善IBD患者的长期结果至关重要.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
365
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
365
Inflammatory Bowel Disease IV: Pharmacological Management
159
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
159
Inflammatory Bowel Disease II: Crohn's Disease
306
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
306
Inflammatory Bowel Disease I: Ulcerative Colitis
227
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
227
Inflammatory Bowel Disease V: Surgical Management
174
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
174
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
205
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
205


